SCHEMBL13993247

SCHEMBL13993247

CC(=O)c1c(C(C)=O)c(C)n(-c2ccc(O)cc2)c1C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.68
NPC1 O15118 1/20 0.66
TSHR P16473 3/20 0.64
MAPK1 P28482 3/20 0.64
HTT P42858 4/20 0.60
GAA P10253 4/20 0.60
SMN1; SMN2 Q16637 3/20 0.60
MAPT P10636 3/20 0.60
LMNA P02545 2/20 0.60
POLB P06746 1/20 0.58
THRB P10828 1/20 0.57
HPGD P15428 3/20 0.54
HIF1A Q16665 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
KMT2A Q03164 3/20 0.49
KDM4E B2RXH2 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
GFER P55789 1/20 0.44
MEN1 O00255 2/20 0.42
PKM P14618 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13993248 0.86 ALDH1A1 (0.70) ALDH1A1NPC1TSHRMAPK1HTT
SCHEMBL11334221 0.82 ALDH1A1 (0.70) ALDH1A1NPC1TSHRMAPK1HTT
SCHEMBL13993246 0.79 NPC1 (1.00) ALDH1A1NPC1TSHRMAPK1HTT
SCHEMBL5004947 0.78 THRB (0.69) ALDH1A1NPC1TSHRMAPK1HTT
SCHEMBL5004946 0.75 THRB (0.56) ALDH1A1NPC1TSHRMAPK1HTT
SCHEMBL5000991 0.74 HTT (0.49) ALDH1A1NPC1TSHRMAPK1HTT
SCHEMBL5007960 0.74 HPGD (0.49) ALDH1A1NPC1TSHRMAPK1HTT
SCHEMBL5009780 0.73 ALDH1A1 (0.78) ALDH1A1NPC1TSHRMAPK1HTT
SCHEMBL11793679 0.73 MEN1 (0.55) ALDH1A1NPC1MAPK1HTTGAA
SCHEMBL13576515 0.71 HPGD (1.00) ALDH1A1TSHRMAPK1HTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465730-B2 Treatment of neuropathic pain with 6H-pyrrolo[3,4-d]pyridazine compounds MERCK & CO. INC. (US) 2008-12-16 US disclosed